Copyright

(c) 2016 Jon L Gelman, All Rights Reserved.

Tuesday, October 28, 2014

IMIG 2014: Mesothelioma: Cancer stem cells by defactinib, a novel inhibitor of FAK


Paul Baas summarizes evidence from studies showing specific targeting of cancer stem cells by defactinib, a novel inhibitor of FAK.